Contact
searchSearch
HMP Global

Non-Small Cell Lung Cancer Topic Center

Hsu Headshot
Videos
Understanding the Changing Landscape of NSCLC in the US
07/11/2025
Melinda Hsu, MD
Dr. Melinda Hsu, thoracic oncologist and cancer survivorship director at UH Simon Cancer Center, shares insights on the evolving landscape of non–small cell lung cancer—highlighting challenges in early detection, treatment tolerability, and...
Dr. Melinda Hsu, thoracic oncologist and cancer survivorship director at UH Simon Cancer Center, shares insights on the evolving landscape of non–small cell lung cancer—highlighting challenges in early detection, treatment tolerability, and...
Dr. Melinda Hsu, thoracic...
07/11/2025
First Report Managed Care
Rodriguez Headshot
Videos
Addressing Disparities in NSCLC With Timely Biomarker Testing and Navigation Tools
07/11/2025
Estelamari Rodriguez, MD, MPH
Dr. Estelamari Rodriguez, clinical research lead for thoracic oncology at the University of Miami Sylvester Cancer Center, explores how early biomarker testing, equitable access, artificial intelligence (AI)-driven data integration, and...
Dr. Estelamari Rodriguez, clinical research lead for thoracic oncology at the University of Miami Sylvester Cancer Center, explores how early biomarker testing, equitable access, artificial intelligence (AI)-driven data integration, and...
Dr. Estelamari Rodriguez,...
07/11/2025
First Report Managed Care
Thawani
Videos
Advancing NSCLC Care: Targeted Strategies, Real-World Barriers, and the Future of Treatment Pathways
07/11/2025
Rajat Thawani, MD
Dr. Rajat Thawani, a thoracic oncologist at OHSU Knight Cancer Institute, discusses groundbreaking advances in lung cancer treatment—highlighting the promise of antibody-drug conjugates (ADCs), the critical role of biomarker testing, and the...
Dr. Rajat Thawani, a thoracic oncologist at OHSU Knight Cancer Institute, discusses groundbreaking advances in lung cancer treatment—highlighting the promise of antibody-drug conjugates (ADCs), the critical role of biomarker testing, and the...
Dr. Rajat Thawani, a thoracic...
07/11/2025
First Report Managed Care
News
Medicaid Expansion Linked to Improved Access to Local Therapy for Early-Stage Lung Cancer
06/09/2025
Juliet Gallagher
A recent retrospective study using the National Cancer Database suggests that Medicaid expansion under the Affordable Care Act (ACA) may improve access to local therapy—surgery or stereotactic body radiation therapy (SBRT)—for patients with...
A recent retrospective study using the National Cancer Database suggests that Medicaid expansion under the Affordable Care Act (ACA) may improve access to local therapy—surgery or stereotactic body radiation therapy (SBRT)—for patients with...
A recent retrospective study...
06/09/2025
First Report Managed Care
News
Immune Checkpoint Inhibitor Regimens Drive Higher Costs in First-Line NSCLC Treatment
05/13/2025
Lisa Kuhns, PhD, MD
First-line (1L) treatment with immune checkpoint inhibitors (ICIs), particularly in combination with chemotherapy, is the most frequently used and costliest systemic therapy for metastatic non-small cell lung cancer (NSCLC) patients without...
First-line (1L) treatment with immune checkpoint inhibitors (ICIs), particularly in combination with chemotherapy, is the most frequently used and costliest systemic therapy for metastatic non-small cell lung cancer (NSCLC) patients without...
First-line (1L) treatment with...
05/13/2025
First Report Managed Care
News
Continued Immunotherapy Beyond Progression May Extend Survival in Metastatic NSCLC
04/23/2025
Grace Taylor, MS, MA
Study finds extended survival with immunotherapy beyond disease progression for patients with non–small cell lung cancer.
Study finds extended survival with immunotherapy beyond disease progression for patients with non–small cell lung cancer.
Study finds extended survival...
04/23/2025
First Report Managed Care
News
Study Quantifies How Social and Structural Factors Drive Racial Inequities in NSCLC Care
04/11/2025
Lisa Kuhns, PhD, MD
Black patients with non-small cell lung cancer (NSCLC) in the US experience significantly worse care and outcomes compared with White patients, and these disparities are largely explained by exposure to structural racism across the health...
Black patients with non-small cell lung cancer (NSCLC) in the US experience significantly worse care and outcomes compared with White patients, and these disparities are largely explained by exposure to structural racism across the health...
Black patients with non-small...
04/11/2025
First Report Managed Care
Conference Coverage
Polygenic Risk Scores May Improve Early Detection of Non–Small Cell Lung Cancer
04/01/2025
Grace Taylor, MS, MA
New research shows that polygenic risk scores may enhance the prediction of non–small cell lung cancer (NSCLC) risk by highlighting key genetic mutations.
New research shows that polygenic risk scores may enhance the prediction of non–small cell lung cancer (NSCLC) risk by highlighting key genetic mutations.
New research shows that...
04/01/2025
First Report Managed Care
News
Immune-Related Adverse Events With ICIs Linked to Improved Survival in Metastatic NSCLC
12/09/2024
Jolynn Tumolo
Developing a clinically meaningful immune-related adverse event (irAE) was associated with significantly improved overall survival in patients with locally advanced or metastatic non–small cell lung cancer (NSCLC) treated with immune...
Developing a clinically meaningful immune-related adverse event (irAE) was associated with significantly improved overall survival in patients with locally advanced or metastatic non–small cell lung cancer (NSCLC) treated with immune...
Developing a clinically...
12/09/2024
First Report Managed Care
Research Review
How to Implement a Multidisciplinary Team Approach to Improve NSCLC Treatment
11/25/2024
Hannah Musick
Learn about the crucial role of multidisciplinary team care coordination in improving outcomes for patients with early-stage non-small cell lung cancer, as discussed at AVAHO 2024, along with supporting research showing that MDT-based patient...
Learn about the crucial role of multidisciplinary team care coordination in improving outcomes for patients with early-stage non-small cell lung cancer, as discussed at AVAHO 2024, along with supporting research showing that MDT-based patient...
Learn about the crucial role of...
11/25/2024
First Report Managed Care
Interactive Features
Poll Quiz

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use